Search

Your search keyword '"Ciruolo, A."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Ciruolo, A." Remove constraint Author: "Ciruolo, A." Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
35 results on '"Ciruolo, A."'

Search Results

1. PB1865: NPM1-MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS

2. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma

4. PB1865: NPM1-MUT MONITORING DURING GILTERITINIB TREATMENT IDENTIFIES DIFFERENT DYNAMICAL PATTERNS IN RESPONSIVE PATIENTS

5. A venetoclax and azacitidine bridge‐to‐transplant strategy for NPM1 ‐ mutated acute myeloid leukaemia in molecular failure

6. OC.12.4 PROGNOSTIC FACTORS IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) TREATED WITH LENVATINIB

8. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

9. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma

12. Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology

13. Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma

16. Higher Efficiency of Percutaneous Microwave (MWA) Than Radiofrequency Ablation (RFA) in Achieving Complete Response in Cirrhotic Patients with Early Hepatocellular Carcinoma

17. Alpha-Fetoprotein, Protein Induced by Vitamin K Absence or Antagonist II and Glypican-3 for the Detection and Prediction of Hepatocellular Carcinoma in Patients with Cirrhosis of Viral Etiology

18. Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma

19. Serum cytokeratin-19 fragments (CYFRA 21–1) for the prediction of overall survival in patients with hepatocellular carcinoma

20. Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3)

21. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study

22. Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3)

23. Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single-center retrospective study

24. THU-189-Role of comorbidites in sofosbuvir-based treatment response: Clinical experience from an Italian real life cohort

28. FRI-464-Percutaneous microwave is better than radiofrequency ablation to obtain complete response in cirrhotic patients with very early and early hepatocellular carcinoma

31. Percutaneous microwave (MW) is superior to radiofrequency ablation (RFA) to induce complete response in cirrhotic patients with very early and early hepatocellular carcinoma (HCC)

32. Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

33. N-3 fatty acids in patients with multiple cardiovascular risk factors

34. T Cell/Natural Killer (NK) Cell Transcriptional Profiles Are Associated with Response to Gilteritinib in FLT3-Mutated Acute Myeloid Leukemia

35. THU467 - Serum cytokeratin-19 fragments (CYFRA 21–1) for the prediction of overall survival in patients with hepatocellular carcinoma.

Catalog

Books, media, physical & digital resources